The modern spectrum of biopsy-proven renal disease in Chinese diabetic patients—a retrospective descriptive study

Background Renal biopsies performed in diabetic patients are increasing and becoming more complex. Comprehensive data on modern spectrum of biopsy-proven renal disease in Chinese diabetic patients are lacking. Methods In a nationwide renal biopsy survey including 71,151 native biopsies from 2004 to...

Full description

Bibliographic Details
Main Authors: Diankun Liu, Ting Huang, Nan Chen, Gang Xu, Ping Zhang, Yang Luo, Yongping Wang, Tao Lu, Long Wang, Mengqi Xiong, Jian Geng, Sheng Nie
Format: Article
Language:English
Published: PeerJ Inc. 2018-03-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/4522.pdf
_version_ 1797424108022005760
author Diankun Liu
Ting Huang
Nan Chen
Gang Xu
Ping Zhang
Yang Luo
Yongping Wang
Tao Lu
Long Wang
Mengqi Xiong
Jian Geng
Sheng Nie
author_facet Diankun Liu
Ting Huang
Nan Chen
Gang Xu
Ping Zhang
Yang Luo
Yongping Wang
Tao Lu
Long Wang
Mengqi Xiong
Jian Geng
Sheng Nie
author_sort Diankun Liu
collection DOAJ
description Background Renal biopsies performed in diabetic patients are increasing and becoming more complex. Comprehensive data on modern spectrum of biopsy-proven renal disease in Chinese diabetic patients are lacking. Methods In a nationwide renal biopsy survey including 71,151 native biopsies from 2004 to 2014, diabetic patients were identified according to the clinical diagnosis from referral records. The clinical data were extracted from referral records and pathological reports. Results A total of 1,604 diabetic patients, including 61 patients with T1DM, were analyzed in this study. The median age is 51.39 ± 11.37 years. Male patients accounted for 58% of the population. We found that only 44.7% of diabetic patients had the isolated pathological diagnosis of diabetic nephropathy (DN), while 49.1% had non-diabetic renal disease (NDRD) alone, and 6.2% had NDRD superimposed on DN. Nephrotic syndrome (n = 824, 51.4%) was the most common clinical indication for renal biopsy. Among 887 patients with NDRD, membranous nephropathy (n = 357) was the leading diagnosis, followed by IgA nephropathy (n = 179). Hypertensive renal disease (n = 32), tubulointerstitial nephropathy (n = 27) and acute tubular necrosis (n = 16) accounted for 3.5%, 2.9%, 1.7% of the NDRD cases respectively. Nearly a half (49.2%) of patients with T1DM had NDRD. Discussion Over 55% diabetic patients with kidney disease were diagnosed as non-diabetic renal disease, among which MN and IgAN were the most common two pathological types.
first_indexed 2024-03-09T07:57:29Z
format Article
id doaj.art-57adae2c4b804fc187a575251aafd6bd
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T07:57:29Z
publishDate 2018-03-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-57adae2c4b804fc187a575251aafd6bd2023-12-03T00:51:40ZengPeerJ Inc.PeerJ2167-83592018-03-016e452210.7717/peerj.4522The modern spectrum of biopsy-proven renal disease in Chinese diabetic patients—a retrospective descriptive studyDiankun Liu0Ting Huang1Nan Chen2Gang Xu3Ping Zhang4Yang Luo5Yongping Wang6Tao Lu7Long Wang8Mengqi Xiong9Jian Geng10Sheng Nie11The National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaThe National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaRuijin Hospital, Shanghai Jiao Tong University, Shanghai, ChinaTongji Hospital, Huazhong University of Science and Technology, Wuhan, ChinaSichuan Provincial People’s Hospital, Sichuan Academy of Medical Science, Chengdu, ChinaBeijing Shijitan Hospital, Capital Medical University, Beijing, ChinaThe National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaThe National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaThe National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaThe National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaKing Medical Diagnostics Center, Guangzhou, ChinaThe National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, ChinaBackground Renal biopsies performed in diabetic patients are increasing and becoming more complex. Comprehensive data on modern spectrum of biopsy-proven renal disease in Chinese diabetic patients are lacking. Methods In a nationwide renal biopsy survey including 71,151 native biopsies from 2004 to 2014, diabetic patients were identified according to the clinical diagnosis from referral records. The clinical data were extracted from referral records and pathological reports. Results A total of 1,604 diabetic patients, including 61 patients with T1DM, were analyzed in this study. The median age is 51.39 ± 11.37 years. Male patients accounted for 58% of the population. We found that only 44.7% of diabetic patients had the isolated pathological diagnosis of diabetic nephropathy (DN), while 49.1% had non-diabetic renal disease (NDRD) alone, and 6.2% had NDRD superimposed on DN. Nephrotic syndrome (n = 824, 51.4%) was the most common clinical indication for renal biopsy. Among 887 patients with NDRD, membranous nephropathy (n = 357) was the leading diagnosis, followed by IgA nephropathy (n = 179). Hypertensive renal disease (n = 32), tubulointerstitial nephropathy (n = 27) and acute tubular necrosis (n = 16) accounted for 3.5%, 2.9%, 1.7% of the NDRD cases respectively. Nearly a half (49.2%) of patients with T1DM had NDRD. Discussion Over 55% diabetic patients with kidney disease were diagnosed as non-diabetic renal disease, among which MN and IgAN were the most common two pathological types.https://peerj.com/articles/4522.pdfRenal biopsyDiabetic nephropathyNon-diabetic renal diseaseDiabetes mellitusMembranous nephropathy
spellingShingle Diankun Liu
Ting Huang
Nan Chen
Gang Xu
Ping Zhang
Yang Luo
Yongping Wang
Tao Lu
Long Wang
Mengqi Xiong
Jian Geng
Sheng Nie
The modern spectrum of biopsy-proven renal disease in Chinese diabetic patients—a retrospective descriptive study
PeerJ
Renal biopsy
Diabetic nephropathy
Non-diabetic renal disease
Diabetes mellitus
Membranous nephropathy
title The modern spectrum of biopsy-proven renal disease in Chinese diabetic patients—a retrospective descriptive study
title_full The modern spectrum of biopsy-proven renal disease in Chinese diabetic patients—a retrospective descriptive study
title_fullStr The modern spectrum of biopsy-proven renal disease in Chinese diabetic patients—a retrospective descriptive study
title_full_unstemmed The modern spectrum of biopsy-proven renal disease in Chinese diabetic patients—a retrospective descriptive study
title_short The modern spectrum of biopsy-proven renal disease in Chinese diabetic patients—a retrospective descriptive study
title_sort modern spectrum of biopsy proven renal disease in chinese diabetic patients a retrospective descriptive study
topic Renal biopsy
Diabetic nephropathy
Non-diabetic renal disease
Diabetes mellitus
Membranous nephropathy
url https://peerj.com/articles/4522.pdf
work_keys_str_mv AT diankunliu themodernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT tinghuang themodernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT nanchen themodernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT gangxu themodernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT pingzhang themodernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT yangluo themodernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT yongpingwang themodernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT taolu themodernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT longwang themodernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT mengqixiong themodernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT jiangeng themodernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT shengnie themodernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT diankunliu modernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT tinghuang modernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT nanchen modernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT gangxu modernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT pingzhang modernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT yangluo modernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT yongpingwang modernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT taolu modernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT longwang modernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT mengqixiong modernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT jiangeng modernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy
AT shengnie modernspectrumofbiopsyprovenrenaldiseaseinchinesediabeticpatientsaretrospectivedescriptivestudy